Fenghuang Zhan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 21

Top Topics

Low Density Lipoprotein

Multiple Myeloma

Cell Cycle Arrest

Top Venues

Nature communications

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu, Dongzheng Gai, Eric Robb Siegel, Clyde Bailey, Timothy Cody Ashby, Samer Al Hadidi, Carolina D Schinke, Sharmilan Thanendrarajan, Yupo Ma, Qing Yi, Robert Z Orlowski, Maurizio Zangari, Frits Van Rhee, Siegfried Janz, Gail A Bishop, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nature communications 15 (1) (2024)
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, Fumou Sun, Anita D Souza, Binod Dhakal, Parameswaran N Hari, Quillan Huang, Paul Auer, Yong Li, Raul Urrutia, Fenghuang Zhan, John D Shaughnessy, Siegfried Janz, Jing Dong, Chao Cheng
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood cancer journal 14 (1) (2024)
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, Fumou Sun, Anita D Souza, Binod Dhakal, Parameswaran N Hari, Quillan Huang, Paul Auer, Yong Li, Raul Urrutia, Fenghuang Zhan, John D Shaughnessy, Siegfried Janz, Jing Dong, Chao Cheng
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood cancer journal 14 (1) (2024)
Wancheng Guo, Yihao Zhan, David Mery, Eric Robb Siegel, Fumou Sun, Yan Cheng, Timothy Cody Ashby, Zijun Zhang, Clyde Bailey, Daisy V Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina D Schinke, Maurizio Zangari, Frits Van Rhee, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems. Blood cancer journal 14 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Wancheng Guo, Yihao Zhan, David Mery, Eric Robb Siegel, Fumou Sun, Yan Cheng, Timothy Cody Ashby, Zijun Zhang, Clyde Bailey, Daisy V Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina D Schinke, Maurizio Zangari, Frits Van Rhee, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems. Blood cancer journal 14 (1) (2024)
Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu, Dongzheng Gai, Eric Robb Siegel, Clyde Bailey, Timothy Cody Ashby, Samer Al Hadidi, Carolina D Schinke, Sharmilan Thanendrarajan, Yupo Ma, Qing Yi, Robert Z Orlowski, Maurizio Zangari, Frits Van Rhee, Siegfried Janz, Gail A Bishop, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nature communications 15 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu, Dongzheng Gai, Eric Robb Siegel, Clyde Bailey, Timothy Cody Ashby, Samer Al Hadidi, Carolina D Schinke, Sharmilan Thanendrarajan, Yupo Ma, Qing Yi, Robert Z Orlowski, Maurizio Zangari, Frits Van Rhee, Siegfried Janz, Gail A Bishop, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nature communications 15 (1) (2024)
Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu, Dongzheng Gai, Eric Robb Siegel, Clyde Bailey, Timothy Cody Ashby, Samer Al Hadidi, Carolina D Schinke, Sharmilan Thanendrarajan, Yupo Ma, Qing Yi, Robert Z Orlowski, Maurizio Zangari, Frits Van Rhee, Siegfried Janz, Gail A Bishop, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nature communications 15 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Jian-Rong Li, Shahram Arsang-Jang, Yan Cheng, Fumou Sun, Anita D Souza, Binod Dhakal, Parameswaran N Hari, Quillan Huang, Paul Auer, Yong Li, Raul Urrutia, Fenghuang Zhan, John D Shaughnessy, Siegfried Janz, Jing Dong, Chao Cheng
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood cancer journal 14 (1) (2024)
Fumou Sun, Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu, Dongzheng Gai, Eric Robb Siegel, Clyde Bailey, Timothy Cody Ashby, Samer Al Hadidi, Carolina D Schinke, Sharmilan Thanendrarajan, Yupo Ma, Qing Yi, Robert Z Orlowski, Maurizio Zangari, Frits Van Rhee, Siegfried Janz, Gail A Bishop, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nature communications 15 (1) (2024)
Wancheng Guo, Yihao Zhan, David Mery, Eric Robb Siegel, Fumou Sun, Yan Cheng, Timothy Cody Ashby, Zijun Zhang, Clyde Bailey, Daisy V Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina D Schinke, Maurizio Zangari, Frits Van Rhee, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems. Blood cancer journal 14 (1) (2024)
Wancheng Guo, Yihao Zhan, David Mery, Eric Robb Siegel, Fumou Sun, Yan Cheng, Timothy Cody Ashby, Zijun Zhang, Clyde Bailey, Daisy V Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina D Schinke, Maurizio Zangari, Frits Van Rhee, Guido Tricot, John D Shaughnessy, Fenghuang Zhan
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems. Blood cancer journal 14 (1) (2024)
Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yanqiang Li, Robert Z Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian, Qing Yi
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature communications 15 (1) (2024)
Mason McCrury, Kennith Swafford, Sydnye L Shuttleworth, Syed Hassan Mehdi, Baku Acharya, Debasmita Saha, Kevin Naceanceno, Stephanie D Byrum, Aaron J Storey, Ying-Zhi Xu, Claire Doshier, Vijay Patel, Ginell R Post, Annick De Loose, Analiz Rodriguez, Leonard D Shultz, Fenghuang Zhan, Donghoon Yoon, Brendan Frett, Samantha Kendrick
Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma. Molecular cancer therapeutics (2023)
Li Xu, Yingcong Wang, Guanli Wang, Shushan Guo, Dandan Yu, Qilin Feng, Ke Hu, Gege Chen, Bo Li, Zhijian Xu, Xinyan Jia, Yumeng Lu, Hui Zhang, Xuejie Gao, Shuaikang Chang, Huaping Wang, Xiaosong Wu, Dongliang Song, Guang Yang, Huabin Zhu, Jinfeng Zhou, Fenghuang Zhan, Jianming Zhu, Jumei Shi
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma. Leukemia (2023)
Samer Al Hadidi, Obada E Ababneh, Carolina D Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert T Smith, Susan Panozzo, Daisy Alapat, Michele Cottler-Fox, Guido J Tricot, John D Shaughnessy, Fenghuang Zhan, Jeffrey R Sawyer, Bart Barlogie, Maurizio Zangari, Frits van Rhee
Three Years Maintenance with VRD in Multiple Myeloma: Results of Total Therapy IIIB with a 15-Year Follow Up. Blood advances (2023)
Yan Cheng, Fumou Sun, Krista Thornton, Xuefang Jing, Jing Dong, Grant Yun, Michael Pisano, Fenghuang Zhan, Sung Hoon Kim, John A Katzenellenbogen, Benita S Katzenellenbogen, Parameswaran Hari, Siegfried Janz
FOXM1 regulates glycolysis and energy production in multiple myeloma. Oncogene 41 (32) (2022)